Explore evidence

Vector parous rates were unaltered by the intervention.

Kenyapaludismeobserved May 1994 to April 1995published 1996Medical and veterinary entomologyeurope_pmcdocument of 5 observations

317 individualsIn a nested case-control design, 317 individuals who developed clinical malaria (cases) were matched 1:1 by age and village with 317 individuals who did not (controls).

Kenyapaludismepublished 2025The American journal of tropical medicine and hygienePubMeddocument of 6 observations

70,500,000 pregnanciesIn 2007, 70.5 million pregnancies occurred in areas with exceptionally low malaria transmission or with Plasmodium vivax only.

Kenyapaludismeobserved 2007published 2010PLoS medicineeurope_pmcdocument of 11 observations

38.2 %Of the RT drug-resistant mutations, 13 (38.2%) were seen in RNA only, 6 (17.6%) in DNA only, and 15 (44.1%) in both.

KenyaVIH/sidapublished 2007Journal of clinical microbiologyeurope_pmcdocument of 4 observations

53.8 %The 3-year disease-free survival was 53.8% among people living with HIV.

Kenyacancer du col de l'utérusobserved 2014–2023published 2026BMC cancerPubMeddocument of 16 observations

95.1 %Of patients with a positive malaria test result, 95.1% were prescribed artemether-lumefantrine (AL).

Kenyapaludismepublished 2022Malaria journaleurope_pmcdocument of 10 observationsDOI 10.1186/s12936-022-04048-2

86 infantsAmong 187 mother-infant pairs with postpartum data, 86 (46%) infants were HIV-exposed, uninfected (CHEU) and 101 (54%) were HIV-unexposed, uninfected (CHUU).

KenyaVIH/sidapublished 2025BMJ global healthPubMeddocument of 10 observations

312 ng/mLThe geometric mean P. falciparum histidine-rich protein 2 (PfHRP2) concentration was 312 ng/mL in the subgroup of patients with severe malaria and concomitant invasive bacterial infections of blood or cerebrospinal fluid.

Kenyapaludismepublished 2021Clinical infectious diseases : an official publication of the Infectious Diseases Society PubMeddocument of 6 observations

There were no differences in infant length or weight at 6 weeks, 6 months, and 9 months between children with and without prenatal PrEP exposure, including underweight, stunting, and wasting.

Kenyamalnutritionpublished 2025The Lancet. Global healthPubMeddocument of 5 observations

24 %Twenty-four percent of enrolled women were HIV positive.

KenyaVIH/sidapublished 2022The American journal of tropical medicine and hygienePubMeddocument of 8 observations

57.2 %Among 208 HIV-infected ART-naïve adults in Kenya, 119 (57.2%) had no hepatitis B virus (HBV) markers.

Kenyahépatite B · VIH/sidapublished 2021PloS onePubMeddocument of 7 observations

2 %The Plasmodium falciparum sporozoite rate of An. funestus in Bungoma was 2% (3/174).

Kenyapaludismepublished 2021PloS onePubMeddocument of 13 observations

Age-standardized incidence rates of colorectal cancer were increasing in all of the populations studied across 11 sub-Saharan African countries.

Kenyacolorectal cancerpublished 2024International journal of cancereurope_pmcdocument of 5 observations

4,400 children/youthThe target enrolment for the cross-sectional cohort is 4400 children/youth (4000 HIV-exposed uninfected and 400 HIV-unexposed uninfected).

KenyaVIH/sidapublished 2024BMJ openPubMeddocument of 4 observations

6 %6% of all malaria infections were among children aged less than 1 year in the lake endemic zone.

Kenyapaludismepublished 2016Malaria journaleurope_pmcdocument of 12 observations

0.5 %In the Republic of Djibouti, 42 out of 7151 individuals tested using rapid diagnostic tests were positive for Plasmodium falciparum infection and confirmed by PCR, representing a prevalence of 0.5%.

Kenyapaludismeobserved 2008–2009published 2011BMC infectious diseaseseurope_pmcdocument of 5 observations

79 %In the SEARCH Study in rural Kenya and Uganda (2013–2017), 79% of HIV-positive persons had viral suppression at year 3 according to fully adjusted estimates.

KenyaVIH/sidaobserved 2013-2017published 2020Epidemiology (Cambridge, Mass.)PubMeddocument of 8 observations

76.5 %76.5% of women previously screened for cervical cancer had one prior screening.

Kenyacancer du col de l'utéruspublished 2025BMC women's healthPubMeddocument of 8 observations

6 genomesAll six recovered SARS-CoV-2 genomes classified within the 501Y.V2 variant of concern (lineage B.1.351).

Kenya501Y.V2 variant of concern · COVID-19 · lineage B.1.351published 2021Wellcome open researcheurope_pmcdocument of 3 observations

G6PD c.202T homo/heterozygosity was positively associated with severe pneumonia.

Kenyapneumonie sévèrepublished 2020Blood advancesPubMeddocument of 11 observations

6 %Cough occurred in 6% of participants as an adverse event after yellow fever vaccination.

Kenyafièvre jaunepublished 2023The Lancet. Infectious diseasesPubMeddocument of 7 observations

16.3 %38 (16.3%) patients had suboptimal nevirapine plasma levels of <3400 ng/mL.

KenyaVIH/sidapublished 2022MedicinePubMeddocument of 7 observations

7 %Plasmodium falciparum prevalence declined progressively between 2008 and 2012 to ≤ 7% in both Magoda and Mpapayu villages.

Kenyapaludismeobserved 2008-2012published 2018Malaria journaleurope_pmcdocument of 10 observations

46 %Fourth dose coverage of the RTS,S malaria vaccine had a median of 46% in 2023 across Ghana, Kenya, and Malawi.

Kenyapaludismeobserved 2023published 2025Malaria journalPubMeddocument of 4 observations

56.8 %Among women who engaged in pica, 56.8% reported geophagy, charcoal, and/or ash consumption.

Kenyapicapublished 2019International journal of environmental research and public healtheurope_pmcdocument of 6 observations